Studies on Emergent Diarrheagenic E. coli Pathogens

突发性腹泻大肠杆菌的研究

基本信息

  • 批准号:
    8597997
  • 负责人:
  • 金额:
    $ 36.2万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-12-15 至 2017-11-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Childhood diarrhea leads to 2 million deaths every year among children less than 5 years of age mainly in underserved countries. E. coli pathogens are believed to be the second most common cause of death after Rotavirus. Six categories of diarrheagenic E. coli have been known to cause diarrhea, yet, recent studies by our group have identified a new diarrheagenic category designated localized adherent E. coli (LAEC) that is significantly associated with childhood diarrhea in Colombia, South America. The long term goal of this study is to understand the epidemiology and the molecular mechanisms of pathogenesis of this new LAEC emergent pathogen. The first specific aim proposes to evaluate the frequency and association of LAEC with childhood diarrhea by conducting two international multicenter case-control studies. We hypothesize that LAEC is associated with childhood diarrhea in children less than 5 years of age living in developing countries. The second specific aim will explain how LAEC virulence factors are essential to cause disease in a piglet model of human infection. We hypothesize that the type IV bundle-forming pilus and a novel type III secretion system directing bacterial-cell invasion are directly associated with the pathogenesis of LAEC diarrhea. The last specific aim will conduct genome DNA sequencing analysis of LAEC strains to identify the genetic elements that resulted in the emergence of LAEC as a pathogen. We hypothesize that LAEC shares in common well defined virulence genes that were acquired by horizontal gene transfer. This project if significant because it will bring fundamental knowledge on the epidemiology, genetics, and pathogenesis of LAEC and will generate molecular biology tools to facilitate future studies on LAEC diarrhea epidemiology, prevention measures and vaccine development research.
描述(由申请人提供):儿童腹泻每年导致200万5岁以下儿童死亡,主要发生在服务不足的国家。E.大肠杆菌病原体被认为是仅次于轮状病毒的第二大常见死因。6种常见的致菌E.已知大肠杆菌会引起腹泻,然而,我们小组最近的研究已经确定了一种新的肠源性类别,称为局部粘附性大肠杆菌。大肠杆菌(LAEC)与南美哥伦比亚的儿童腹泻显著相关。本研究的长期目标是了解这种新的LAEC突发病原体的流行病学和发病机制的分子机制。第一个具体目标是通过进行两项国际多中心病例对照研究来评估LAEC与儿童腹泻的频率和相关性。我们假设LAEC与生活在发展中国家的5岁以下儿童的儿童腹泻有关。第二个具体目标将解释LAEC毒力因子是如何在人类感染的仔猪模型中引起疾病的。我们推测,IV型菌毛形成菌毛和一种新的III型分泌系统直接指导细菌细胞入侵LAEC腹泻的发病机制。最后一个具体目标是对LAEC菌株进行基因组DNA测序分析,以确定导致LAEC作为病原体出现的遗传因素。我们假设LAEC共享通过水平基因转移获得的共同的明确定义的毒力基因。该项目意义重大,因为它将带来LAEC流行病学,遗传学和发病机制的基础知识,并将产生分子生物学工具,以促进LAEC腹泻流行病学,预防措施和疫苗开发研究的未来研究。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Oscar G GOMEZ其他文献

Oscar G GOMEZ的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Oscar G GOMEZ', 18)}}的其他基金

Studies on Emergent Diarrheagenic E. coli Pathogens
突发性腹泻大肠杆菌的研究
  • 批准号:
    8434600
  • 财政年份:
    2012
  • 资助金额:
    $ 36.2万
  • 项目类别:
Studies on Emergent Diarrheagenic E. coli Pathogens
突发性腹泻大肠杆菌的研究
  • 批准号:
    9252801
  • 财政年份:
    2012
  • 资助金额:
    $ 36.2万
  • 项目类别:
Function of Longus Type IV pili in enterotoxigenic E coli
IV型长菌毛在产肠毒素大肠杆菌中的功能
  • 批准号:
    7900470
  • 财政年份:
    2008
  • 资助金额:
    $ 36.2万
  • 项目类别:
Function of Longus Type IV pili in enterotoxigenic E coli
IV型长菌毛在产肠毒素大肠杆菌中的功能
  • 批准号:
    7511800
  • 财政年份:
    2008
  • 资助金额:
    $ 36.2万
  • 项目类别:
Function of Longus Type IV pili in enterotoxigenic E coli
IV型长菌毛在产肠毒素大肠杆菌中的功能
  • 批准号:
    7681503
  • 财政年份:
    2008
  • 资助金额:
    $ 36.2万
  • 项目类别:

相似海外基金

An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
  • 批准号:
    10057526
  • 财政年份:
    2023
  • 资助金额:
    $ 36.2万
  • 项目类别:
    Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
  • 批准号:
    490105
  • 财政年份:
    2023
  • 资助金额:
    $ 36.2万
  • 项目类别:
    Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
  • 批准号:
    2325465
  • 财政年份:
    2023
  • 资助金额:
    $ 36.2万
  • 项目类别:
    Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
  • 批准号:
    10821172
  • 财政年份:
    2023
  • 资助金额:
    $ 36.2万
  • 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
  • 批准号:
    10766947
  • 财政年份:
    2023
  • 资助金额:
    $ 36.2万
  • 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
  • 批准号:
    10772887
  • 财政年份:
    2023
  • 资助金额:
    $ 36.2万
  • 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 36.2万
  • 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
  • 批准号:
    10748465
  • 财政年份:
    2023
  • 资助金额:
    $ 36.2万
  • 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
  • 批准号:
    10591441
  • 财政年份:
    2023
  • 资助金额:
    $ 36.2万
  • 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
  • 批准号:
    491109
  • 财政年份:
    2023
  • 资助金额:
    $ 36.2万
  • 项目类别:
    Fellowship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了